References
- Dienstag J L. Non-A, non-B hepatitis I. Recognition, epidemiology, and clinical features. Gastro-enterology 1983; 85: 439–462
- Wejstål R, Lindberg J, Lundin P, Norkrans G. Chronic non-A, non-B hepatitis. A long-term follow-up study in 49 patients. Scand J Gastroenterol 1987; 22: 1115–1122
- Mattsson L, Weiland O, Glaumann H. Chronic ncn-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically: Outcome during long-term follow-up a comparison. Liver 1989; 9: 120–127
- Hoofnagle J H, Mullen K D, Jones D B, Rustgi V, Di Bisceglie A, Peters M, Waggoner J G, Park Y, Jones E A. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986; 315: 1575–1578
- Thomson B J, Doran M, Lever A ML, Webster A DB. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1987; 1: 539–541
- Schvarcz R, Weiland O, Glaumann H. Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin. Scand J Infect Dis 1988; 20: 231–232
- Jacyna M R, Brooks M G, Loke R HT, Main J, Murray-Lyon I M, Thomas H C. Randomized controlled trial of interferon alpha (lymfoblastoid interferon) in chronic non-A, non-B hepatitis. Br Med J 1989; 298: 80–82
- Di Bisceglie A M, Kassianides C, Lisker-Melman M, Martin P, Murray L, Hoofnagle J H. A randomized, double blind, placebo-controlled trial of alpha interferon therapy for chronic non A, non B hepatitis. Hepatology 1988; 8: 1222
- Weiland O, Schvarcz R, Wejstål R, Norkrans G, Foberg U, Frydén A. Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B hepatitis: Interim results of a randomized controlled open study. Scand J Infect Dis 1989; 21: 127–132
- Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362
- Kuo G, Choo Q L, Alter H J, Gitnick G L, Redeker A G, Purcell R H, Miyamura T, Dienstag J L, Alter M J, Stevens C E, Tegtmeier G E, Bonino F, Colombo M, Lee W S, Kuo C, Berger K, Shuster J R, Overby L R, Bradley D W, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
- Esteban J I, Esteban R, Viladomiu L, López-Talavera J C, Gonzáles A, Hernández A, Roget M, Vargas V, Genescá J, Buti M, Guardia J, Houghton M, Choo Q L, Kuo G. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Van der Poel C L, Reesink H W, Lelie P N, Leentvaar-Lyupers A, Choo Q L, Kuo G, Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; 2: 297–298
- Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Rape G, Schramm W, Rommel F. Antibodies to hepatitis C virus. Lancet 1989; 2: 324–325
- Broström C, Weiland O. Ett engångsset för leverbiopsi lätthanterligt och med få komplikationer. Läkartidningen 1981; 78: 1543–1544, (In Swedish.)
- Knodell R G, Ishak K G, Black W C, Chen T S, Craig R, Kaplowitz N, Kiernan T W, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–435
- Lindh G, Weiland O, Glaumann H. Application of a numerical scoring system for evaluation of histological outcome in long-term followed patients with chronic hepatitis B. Hepatology 1988; 8: 98–103
- Hoofnagle J H, Di Bisceglie A M. Therapy of chronic viral hepatitis: Chronic hepatitis D and non-A, non-B hepatitis. Viral hepatitis and liver disease, A J Zuckerman. Alan R Liss, New York 1988; 823–830
- Mattsson L, Weiland O, Glaumann H. Application of a numerical scoring system for evaluation of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis: Long-term observations, Submitted
- Alexander G JM, Brahm J, Fagan E A, Smith H M, Daniels H M, Eddleston A LWF, Williams R. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987; 2: 66–69
- Hultcrantz R, Glaumann H, Lindberg G, Hson Nilsson L. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986; 21: 109–113
- Mayet W-J, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büchenfelde K-H. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989; 10: 24–28